sacituzumab govitecan
gilead sciences
['tropics-02', '$gild']
with tropics-02 expectations rock bottom could there be an upside surprise tomorrow? #asco22 $gild
Journalist at Evaluate Vantage. Proudly blocked by @JohnCendpts. Interested in: oncology, immunology. Not interested in: what stock you bought today.